C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
We previously studied two alternative pathway activators, Streptococcus pneumoniae and positively charged liposomes, which react with C-reactive protein (CRP). Binding of CRP to these surfaces initiates classical pathway but blocks alternative pathway activation. In this study, we investigated the mechanism of this inhibition using S. pneumoniae, R36a. R36a were pretreated with CRP (CRP-R36a) or buffer and incubated with C2-deficient human serum to which 125I-labeled C3 had been added. The amount of specific 125I-C3 binding was decreased from 8200 mol/CFU on R36a to 2200 mol/CFU on CRP-R36a. In contrast, when the same experiment was performed with purified factors B, D, P, and C3, in the absence of regulatory proteins, specific 125I-C3 uptake was slightly lower on R36a (6100 mol/CFU) than on CRP-R36a (8100 mol/CFU). The ability of the fixed C3b to inactivate factor B in the presence of factor D was equivalent on the two surfaces. The binding of the regulatory factor H to C3b fixed to R36a and CRP-R36a was compared by using purified 125I-labeled factor H. The ratio of factor H bound to C3 bound was twofold greater on CRP-R36a than on R36a. This increase was found by using C2-deficient serum or purified factors B, D, P, and C3 to fix C3b to the surfaces. The ability of CRP to inhibit C3 binding to R36a was restored by the addition of factors H and I to factors B, D, P, and C3. These results indicate that CRP inhibits alternative pathway activation by increasing regulation of bound C3.
D001667:Binding, Competitive; D002097:C-Reactive Protein / Q000378:metabolism / Q000494:pharmacology*; D003167:Complement Activation; D003179:Complement C3b / Q000378:metabolism*; D003180:Complement C3b Inactivator Proteins / Q000378:metabolism* / Q000494:pharmacology; D017242:Complement Factor H; D017244:Complement Factor I; D003170:Complement Pathway, Alternative; D004347:Drug Interactions; D010450:Endopeptidases / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D016177:Macrophage-1 Antigen; D011951:Receptors, Complement / Q000032:analysis; D013296:Streptococcus pneumoniae / Q000276:immunology* / Q000378:metabolism
C493495:CFH protein, human; D003180:Complement C3b Inactivator Proteins; D016177:Macrophage-1 Antigen; D011951:Receptors, Complement; D003179:Complement C3b; D017242:Complement Factor H; D002097:C-Reactive Protein; D010450:Endopeptidases; D017244:Complement Factor I